Dr. Dirk Voelkel, Chief Technology Officer, Innovation and Analytics Life Science, joined GE Healthcare Life Sciences in July 2012. In his role he manages the R&D and technology portfolio of GE Life Sciences and the Life Science innovation activities.
Previously, Dr. Voelkel headed the Research and Technology department in Roche Diagnostics Diabetes Care Mannheim, developing new technologies to address the needs of diabetic patients world wide. In prior roles he was a technology scout in the San Francisco bay area and a project leader in R&D, developing systems for glucose monitoring.
Before joining industry, Dr. Voelkel was a researcher at the Max-Planck-Institut for Fluid Dynamics in Göttingen, Germany and Sandia National Laboratories, Livermore, CA. He received a doctorate and diploma for Physics of the University of Göttingen. Dr. Voelkel holds 8 patents.
R&D organizations are often well aligned to deliver on budget and in time for incremental innovation, exploiting near term business opportunities with relatively low risk. The culture needed to support such an organization is often prohibiting the exploration of completely new and radical innovation.
We in GE embed entrepreneurial best practices into our R&D management discipline, a test & learn mind-set to transform the way we work.
We will propose cutting-edge approaches to radical innovation and invite discussion for what culture change is required, what experiences the audience can share and how best can we manage both exploitation & exploration that is needed to be successful in a rapidly growing economy with increasing uncertainty.View Details